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Abstract
We read the article entitled “Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion
during 1.5 T MR-guided stereotactic body radiotherapy” with great interest. In that study, the author reported that
there is a statistically significant difference in the rotational antero-posterior shifts between the spacer and the non-
spacer groups. Also, there was no statistically significant difference between the groups in terms of translational
shifts. However, there are some points about the study. In this letter, we aimed to clarify these points.
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To the Editor:
We read with great interest the Cuccia et al. study in-
vestigating the effect of hydrogel rectal spacer on pros-
tate intra-fraction motion during 1.5 T magnetic
resonance imaging (MRI)-guided stereotactic body
radiotherapy (SBRT) [1]. In the study, they reported that
there is a statistically significant difference in the rota-
tional antero-posterior shifts between the spacer (n = 10)
and the non-spacer (n = 10) groups (P = 0.033), with re-
spective median values of − 0.0005° and 0.09°. Also, the
authors observed no statistically significant difference
between the groups in terms of translational shifts. We
appreciate the authors’ efforts to elucidate the role of
peri-rectal hydrogel spacer on prostate motion during
MR-guided prostate SBRT, as primary endpoint.
However, there are some points about the study that
need to be clarified.
First, the results of recent systematic review show that
although many studies have reported that rectal hydro-
gel spacer insertion significantly reduces rectal wall
doses and radiation-induced rectal toxicities, resulting in
improving patient quality of life during prostate radi-
ation therapy, the application of prei-rectal hydrogel spa-
cer does not reduce inter- and intra-fractional prostate
motion [2]. It is worthwhile to mention that the inser-
tion of hydrogel spacer increase the perirectal space,
when it is injected between Denonvilliers’ fascia and the
anterior rectal wall, thereby reducing rectal radiation
doses and rectal toxicities [3, 4]. Of note, hydrogel spa-
cer is not really able to fix the pelvic organs such as
prostate because it cannot control rectal filling. On the
contrary, several studies have demonstrated that the use
of Endorectal balloons and rectal retractor can signifi-
cantly reduce intra-fractional prostate motion because
these devices mainly aim to fix the rectal volume/
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position and consecutively the prostate motion and by
doing that, expanding the rectal wall and therefore spar-
ing more portions of the wall by using a smaller plan-
ning target volume (PTV) [2, 5, 6]. One can hypothesize,
that the application of hydrogel spacer may reduce pros-
tate motion by squeezing the prostate gland towards the
pubic bone, as the possible mechanism. Conversely, the
injection of hydrogel spacer may increase pressure on
the rectal wall causing rectal irritation and discomfort,
resulting in more prostate motion [2, 7].
Second, the authors evaluated intra-fractional prostate
displacements by means of quantifying pre- and post-
fractional deviations of the prostate by MRI. Using MR
imaging is considered as an ideal scenario for image-
guided prostate radiotherapy because of high soft tissue
contrast [8]. It should be noted, however, that using pre-
and post-treatment MRI cannot well clarify the impact
of hydrogel spacer on intra-fractional prostate motion.
In other words, real intra-fractional prostate shifts can-
not be accurately mapped by measuring the position of
the prostate immediately before and after a radiotherapy
treatment fraction. Furthermore, the authors did not use
Cine-MRI to track prostate intra-fraction motion over
the full beam-on period. Real-time motion tracking can
clearly elucidate the effect of hydrogel spacer on prostate
intra-fraction motion, as compared to pre-post imaging.
Third, an interesting point of the study is that the au-
thors assessed both intra-fraction translational and rota-
tional shifts. The authors considered no rotational and
translational shift tolerance. We think that a shift toler-
ance value could be defined and the shifts within toler-
ance value and greater than it between the spacer and
non-spacer cohorts could be compared.
Fourth, the aim of managing prostate motion is
rectal toxicity reduction and increased efficacy by a
lower target miss rate; therefore, it is necessary to
assess the impact of rectal displacement devices (i.e.,
Endorectal balloons, hydrogel spacer, and rectal re-
tractor) on target margins and oncological outcomes
during prostate radiotherapy. There have been nu-
merous studies to assess the effect of rectal displace-
ment devices on prostate motion [2]; however, the
relationship between rectal displacement devices, tar-
get margins, and toxicity data has yet to be clarified.
In fact, motion and toxicity data should be reported
together. Therefore, although the study has not eval-
uated the effect of hydrogel spacer on target mar-
gins, it is the first study reporting motion and
toxicity data when a hydrogel is used during prostate
radiotherapy.
In summary, peri-rectal hydrogel spacer may serve as
an immobilization device for prostate, but further stud-
ies with a large sample size will be required to evaluate
this hypothesis.
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